![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16895-16899, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Memorial Sloan-Kettering Cancer Center,
New York, New York 10021
The precise role of vitamin C in the prevention
of DNA mutations is controversial. Although ascorbic acid has
strong antioxidant properties, it also has pro-oxidant effects in the
presence of free transition metals. Vitamin C was recently reported to
induce the decomposition of lipid hydroperoxides independent of metal interactions, suggesting that it may cause DNA damage. To directly address the role of vitamin C in maintaining genomic integrity we
developed a genetic system for quantifying guanine base mutations induced in human cells under oxidative stress. The assay utilized a
plasmid construct encoding the cDNA for chloramphenicol acetyl transferase modified to contain an amber stop codon, which was restored
to wild type by G to T transversion induced by oxidative stress. The
mutation frequency was determined from the number of plasmids
containing the wild type chloramphenicol acetyl transferase gene
rescued from oxidatively stressed cells. Cells were loaded with vitamin
C by exposing them to dehydroascorbic acid, thereby avoiding
transition metal-related pro-oxidant effects of ascorbic acid. We found
that vitamin C loading resulted in substantially decreased mutations
induced by H2O2. Depletion of glutathione led to cytotoxicity and an increase in
H2O2-induced mutation frequency; however,
mutation frequency was prominently decreased in depleted cells
preloaded with vitamin C. The mutation results correlated with a
decrease in total 8-oxo-guanine measured in genomic DNA of cells loaded
with vitamin C and oxidatively stressed. These findings directly
support the concept that high intracellular concentrations of vitamin C
can prevent oxidation-induced mutations in human cells.
To whom correspondence should be addressed: Memorial
Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Tel.: 212-639-8483; E-mail: d-golde@ski.mskcc.org.
This article has been cited by other articles:
![]() |
Y. Li and H. E. Schellhorn New Developments and Novel Therapeutic Perspectives for Vitamin C J. Nutr., October 1, 2007; 137(10): 2171 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Durant, K. S. Paffett, M. Shrivastav, G. S. Timmins, W. F. Morgan, and J. A. Nickoloff UV Radiation Induces Delayed Hyperrecombination Associated with Hypermutation in Human Cells. Mol. Cell. Biol., August 1, 2006; 26(16): 6047 - 6055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshikawa, K. Hizume, Y. Oda, K. Takeyasu, S. Araki, and K. Yoshikawa Protective Effect of Vitamin C against Double-Strand Breaks in Reconstituted Chromatin Visualized by Single-Molecule Observation Biophys. J., February 1, 2006; 90(3): 993 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. KC, J. M. Carcamo, and D. W. Golde Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury FASEB J, October 1, 2005; 19(12): 1657 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Karasavvas, J. M. Carcamo, G. Stratis, and D. W. Golde Vitamin C protects HL60 and U266 cells from arsenic toxicity Blood, May 15, 2005; 105(10): 4004 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Carcamo, A. Pedraza, O. Borquez-Ojeda, B. Zhang, R. Sanchez, and D. W. Golde Vitamin C Is a Kinase Inhibitor: Dehydroascorbic Acid Inhibits I{kappa}B{alpha} Kinase {beta} Mol. Cell. Biol., August 1, 2004; 24(15): 6645 - 6652. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lutsenko, J. M. Carcamo, and D. W. Golde A Human Sodium-Dependent Vitamin C Transporter 2 Isoform Acts as a Dominant-Negative Inhibitor of Ascorbic Acid Transport Mol. Cell. Biol., April 15, 2004; 24(8): 3150 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Lee, H. J. Lee, Y.-J. Surh, and C. Y. Lee Vitamin C and cancer chemoprevention: reappraisal Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1074 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Golde Vitamin C in Cancer Integr Cancer Ther, June 1, 2003; 2(2): 158 - 159. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |